Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$47.99
1.884.08%
Last update: Oct 7, 4:16 PM
$47.00
0.891.93%
Rigel Pharmaceuticals Inc (RIGL) Stock Price, Quote, News & History
RIGLNASDAQ
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Rigel Pharmaceuticals Inc develops small-molecule drugs for autoimmune, cancer-related, and viral diseases. The firm's primary drug is an oral rheumatoid arthritis drug candidate that has been licensed to AstraZeneca. Astra has taken overall...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Rigel Pharmaceuticals (NASDAQ:RIGL) through any online brokerage.
Other companies in Rigel Pharmaceuticals’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
Rigel Pharmaceuticals has a consensus price target of $53.17.
The stock price for Rigel Pharmaceuticals (NASDAQ: RIGL) is $47 last updated October 7, 2026 at 4:16 PM EDT.
There are no upcoming dividends for Rigel Pharmaceuticals.
Rigel Pharmaceuticals does not have any upcoming earnings scheduled.
There is no upcoming split for Rigel Pharmaceuticals.
Rigel Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
